| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer
|
Bales, Gregory T.
|
|
1996
|
47 |
1S1 |
p. 38-43
6 p.
|
artikel
|
| 2 |
Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II multicenter trial
|
Soloway, Mark S.
|
|
1996
|
47 |
1S1 |
p. 33-37
5 p.
|
artikel
|
| 3 |
Defining the role of antiandrogens in the treatment of prostate cancer
|
McLeod, David G.
|
|
1996
|
47 |
1S1 |
p. 85-89
5 p.
|
artikel
|
| 4 |
Discussion session: Clinical data on the role of bicalutamide in metastatic prostate cancer
|
Richie, Jerome P.
|
|
1996
|
47 |
1S1 |
p. 80-84
5 p.
|
artikel
|
| 5 |
Discussion session: Clinical trials of bicalutamide as monotherapy for prostate cancer
|
Andriole, Gerald L.
|
|
1996
|
47 |
1S1 |
p. 48-53
6 p.
|
artikel
|
| 6 |
Discussion session: The basic science of bicalutamide as a once-daily oral antiandrogen
|
Malkowicz, S.Bruce
|
|
1996
|
47 |
1S1 |
p. 29-32
4 p.
|
artikel
|
| 7 |
Discussion session: The expected value of bicalutamide in the management of prostatic disease
|
Oesterling, Joseph E.
|
|
1996
|
47 |
1S1 |
p. 90-96
7 p.
|
artikel
|
| 8 |
High-dose bicalutamide monotherapy for the treatment of prostate cancer
|
Blackledge, George R.P.
|
|
1996
|
47 |
1S1 |
p. 44-47
4 p.
|
artikel
|
| 9 |
Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer
|
Scher, Howard I.
|
|
1996
|
47 |
1S1 |
p. 61-69
9 p.
|
artikel
|
| 10 |
Hormone therapy for prostate cancer: a topical perspective
|
Klein, Eric A.
|
|
1996
|
47 |
1S1 |
p. 3-12
10 p.
|
artikel
|
| 11 |
Introduction
|
Oesterling, Joseph E.
|
|
1996
|
47 |
1S1 |
p. 1-2
2 p.
|
artikel
|
| 12 |
Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy
|
Schellhammer, Paul
|
|
1996
|
47 |
1S1 |
p. 54-60
7 p.
|
artikel
|
| 13 |
Pharmacodynamics and pharmacokinetics of bicalutamide: defining an active dosing regimen
|
Denis, Louis
|
|
1996
|
47 |
1S1 |
p. 26-28
3 p.
|
artikel
|
| 14 |
The preclinical development of bicalutamide: pharmacodynamics and mechanism of action
|
Furr, B.J.A.
|
|
1996
|
47 |
1S1 |
p. 13-25
13 p.
|
artikel
|
| 15 |
Worldwide activity and safety of bicalutamide: a summary review
|
Kolvenbag, Geert J.C.M.
|
|
1996
|
47 |
1S1 |
p. 70-79
10 p.
|
artikel
|
Tijdschrift beschrijving